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  EVIDENCE-BASED ANSWER 
Case series show that hypokalemia following initiation of diuretic therapy occurs in most patients within 2 to 8 
weeks. However, no studies are available that adequately predict the risk of this complex and multifactorial 
condition. Patients taking diuretics should have a potassium level checked in the first 2 to 8 weeks after 
initiating therapy. Mild hypokalemia (3.1 to 3.4 mmol/L) may be transient, so a repeat measurement may be 
considered before initiating potassium replacement. Dietary sodium restriction may also help to conserve 
potassium, because this will decrease urinary flow rate and potassium loss. The frequency with which to check 
potassium levels should be guided by the patients’ underlying clinical conditions and dietary potassium and 
sodium intake. (Grade of Recommendation: C, based on case series) 
  RECOMMENDATIONS FROM OTHERS 
The National Council on Potassium in Clinical Practice issued a set of guidelines for potassium replacement in 
September 2000.1 The authors recommend using thiazide diuretics at a low dose only (eg, 12.5-25 mg of 
hydrochlorothiazide daily) and adding a potassium-sparing diuretic drug when higher diuretic doses are needed. 
For patients with asymptomatic hypertension they recommend trying to maintain a serum potassium level of at 
least 4.0 mmol/L. The University of Iowa Family Practice Handbook2 states: “Maximal decrease in serum K+ 
concentration is usually seen after 7 days of treatment. Serum K+ concentration should be measured before 
initiation of a diuretic and 1 week after initiation of increase in dose of the diuretic.” 
  EVIDENCE SUMMARY 
Hypokalemia is defined as a serum potassium level less than 3.5 mmol/L (3.5 mEq/L); hypokalemia at levels 
between 3.1 and 3.4 mmol/L is considered mild. The incidence of hypokalemia reported for patients on diuretic 
therapy is broad (7.2% to 56%),3-6 and the time period required to develop hypokalemia varies (1 week6 to >1 
year7). Factors including the type of diuretic used, dosage, duration of use, dietary potassium, and so forth, 
make predicting an individual patient’s progression nearly impossible. Widmer and coworkers5 found that the 
risk of hypokalemia was greatest with concomitant glucocorticoid use, polypharmacy (greater than 12 
medications administered), and female sex. The latter risk factor may be related to a higher dose-to-weight 
relationship. 
Lemieux and colleagues8 followed 50 patients receiving a variety of diuretic regimens (hydrochlorothiazide 50 
to 100 mg daily or every other day with or without reserpine 0.25 mg daily). Only 3 patients in this group had 
potassium levels below 3.5 mmol/L, and all decreases were only transient. Peters and coworkers6 documented 
potassium levels below 3.5 mEq/L in 6 of 19 patients taking hydrochlorothiazide 25 or 50 mg for 20 weeks. 
Three of these patients normalized without therapy. One of these transiently hypokalemic patients was also 
taking triamterene, a potassium-sparing diuretic. 
Potassium-sparing diuretics may not free the clinician from checking a potassium level, however. Penhall and 
coworkers9 found hypokalemia in 24 of 54 patients receiving a fixed-combination diuretic (hydrochlorothiazide 
50 mg and potassium-sparing amiloride 5 mg). Note that the dose of hydrochlorothiazide was higher in this 
study than is generally used today. Most recent studies have found that hydrochlorothiazide in doses above 
12.5 to 25 mg do not result in significantly lower blood pressure and only lead to more electrolyte 
abnormalities.10 
Morgan and Davidson11 performed an analysis of the published data available in 1980. They found that the 
average fall in potassium is less for patients taking furosemide (0.3mmol/L) than on thiazide diuretics 
(0.6mmol/L) and that this fall was only slightly influenced by dose or duration of treatment. 
Clinical Commentary 
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Few hypertensive patients started on low-dose diuretics will become hypokalemic, and most of those 
who do will have serum levels greater than or equal to 3.0 mEq/L. In patients with heart failure or 
renal disease, potassium should be monitored shortly after the initiation of a diuretic because of 
potentially more rapid electrolyte and fluid shifts. However, many of these patients will also be taking 
an ACE inhibitor or spironolactone: 2 drugs that may increase serum potassium levels. In the 
absence of heart failure or renal disease checking a potassium level a month or so following initiation, 
as recommended by this review, seems reasonable. 
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